Novavax Appoints John J. Trizzino as Senior Vice President, Commercial Operations

Novavax Appoints John J. Trizzino as Senior Vice President, Commercial Operations March 10, 2014 Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced the appointment of John J. Trizzino to the position of Senior Vice President, Commercial Operations, effective March 10, 2014. Mr. Trizzino will be responsible for …